Article Details
Retrieved on: 2020-01-03 08:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>SpringWorks Therapeutics (NASDAQ:SWTX)'s stock had its “buy” rating reissued by research analysts at HC Wainwright in a report released on ...</div>
Article found on:
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here